Rheumatoid Arthritis (RA)

Did you know?

Women’s health is an economic issue we can’t afford to ignore.

We FOund:

If we invest $6 million in rheumatoid arthritis research focused on women, we get $10.5 billion in returns to our economy.

We Learned:

Rheumatoid arthritis research focused on women is more than good science, it’s a good investment with a stunning 174,000% return. We improve quality of life, add 32,000 years back to our workforce for patients and caregivers and save $180 million in healthcare costs.

When we add just $6 million for rheumatoid arthritis research focused on women we get large returns:

0
years with RA eliminated
0
years added back to the workforce
$ 0 million
in nursing home costs saved

Doubling NIH funding for women’s RA research pays for itself 1,750 times over.

Investing $6 million in women’s RA research generates $10.5 billion in economic returns.

Research focused on women brings a 174,000% return on investment.

Read the WHAM Report Rheumatoid Arthritis Study Research Brief:

WHAM Report Brief: Societal Impact of Research Funding for Women’s Health in Rheumatoid Arthritis

Without information on the potential return on investment for women’s health research, stakeholders lack a basis for altering research investments to improve knowledge of women’s health. In this report, the authors examine the societal cost impact of increasing research funding in rheumatoid arthritis and find that investing in women’s health research yields benefits beyond investing in general research.

Read the WHAM Report Rheumatoid Arthritis Study Complete Technical Report:

Complete Technical WHAM Report: Societal Impact of Research Funding for Women’s Health in Rheumatoid Arthritis

Erica Ollmann Saphire, President and CEO, La Jolla Institute for Immunology
Scroll to Top